drugset / Trial / NCT07059403
A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults
RandomizedSequentialQuadruple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled, multiple-ascending-dose study of SN2001 in healthy adult subjects. The study is designed to evaluate the safety, tolerability and immunogenicity of SN2001.
Timeline
- Start
- 2025-08-19
- Primary completion
- 2027-04
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SN2001 | Unknown | 100 ug | Subcutaneous |
| Subject | SN2001 | Unknown | 200 ug | Subcutaneous |
| Subject | SN2001 | Unknown | 300 ug | Subcutaneous |